LUNGevity Foundation shared a post on X:
”How are MET-targeted therapies reshaping NSCLC care? Hear from Drs. Goldman, Ross Camidge, and Xiuning Le during ASCO26 as they discuss biomarker testing and personalized treatment strategies.
Join our partners PeerView on 5/30 at 7:00 PM CDT.”
Other Articles About LUNGevity Foundatio on OncoDaily.